Pooled analysis of WHO Surgical Safety Checklist use and mortality after emergency laparotomy.

Related Articles:

• Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. March 19, 2019 Related ArticlesGlobal, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 Mar 14;: Authors: GBD 2016 Neurology Collaborators Abstract BACKGROUND: Neurological disorders are increasingly recognised as major causes of death and disability worldwide. The aim of this analysis from the Global Burden of Diseases, Injuries, and Risk…
• Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial. June 30, 2019 Related ArticlesDeutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Psychiatry. 2017 08;4(8):595-604 Authors: Anderson KE, Stamler D, Davis MD, Factor SA, Hauser RA, Isojärvi J, Jarskog LF, Jimenez-Shahed J, Kumar R, McEvoy JP, Ochudlo S, Ondo WG, Fernandez HH Abstract BACKGROUND: Tardive dyskinesia results from exposure to dopamine…
• Dogs, dyslipidaemia . . . and other stories - The BMJ March 28, 2019 Dogs, dyslipidaemia . . . and other stories  The BMJBMJ 2019; 364 doi: https://doi.org/10.1136/bmj.l1294 (Published 28 March 2019) Cite this as: BMJ 2019;364:l1294. Article · Related *content* · Metrics ...
• Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study. June 24, 2019 Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study. Lancet Neurol. 2019 Jun 19;: Authors: Wilson H, Dervenoulas G, Pagano G, Koros C, Yousaf T, Picillo M, Polychronis S, Simitsi A, Giordano B, Chappell Z, Corcoran B, Stamelou M, Gunn RN, Pellecchia MT, Rabiner EA, Barone P, Stefanis L, Politis M…
• Harrisonburg creates exercise program for people with Parkinson's Disease - The Breeze November 29, 2018 The BreezeHarrisonburg creates exercise program for people with Parkinson's DiseaseThe BreezeHarrisonburg is working with JMU occupational therapy students to help get those with Parkinson's and other neurological disorders get out to exercise. Tags. Parkinsons · Occupational Therapy · Neurological Disorder · Breeze News · Exercise Program.
• Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial. July 7, 2019 Related ArticlesSafety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2019 Jun 27;: Authors: Levin J, Maaß S, Schuberth M, Giese A, Oertel WH, Poewe W, Trenkwalder C, Wenning GK, Mansmann U, Südmeyer M, Eggert K, Mollenhauer B, Lipp A, Löhle M, Classen J, Münchau A, Kassubek J, Gandor F, Berg…
• Global Parkinson's Disease Drugs Market 2019, Trend, CAGR Status, Growth, Analysis and Forecast to 2024 - Thefeedgraph April 14, 2019 Global Parkinson's Disease Drugs Market 2019, Trend, CAGR Status, Growth, Analysis and Forecast to 2024  ThefeedgraphHome · Global Parkinson's Disease Drugs Market 2019, Trend, CAGR Status, Growth, Analysis and Forecast to 2024 · Apr 14, 2019 Ana Alexandre Crypto News ...
• New options for patients with Parkinson's Disease April 12, 2019 The American Parkinson Disease Association (APDA ... Health and wellness activities like tai chi, yoga, stretching, boxing and dance. · Events, services, and resources to facilitate a better quality ...
• Global Parkinson's Disease Drug Market Overview 2019: Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical - Thefeedgraph May 28, 2019 Global Parkinson's Disease Drug Market Overview 2019: Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical  ThefeedgraphHome · Global Parkinson's Disease Drug Market Overview 2019: Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical · May 28, 2019 Zion ...
• UAMS uses boxing to fight Parkinson's - THV11.com KTHV April 16, 2018 THV11.com KTHVUAMS uses boxing to fight Parkinson'sTHV11.com KTHVTHV11s Brejamin Perkins explains how today's forum mixed the "sweet science" with *medical* science to help patients fight Parkinson's. Related Videos. How to make yoga easier on your joints · THV-THIS-MORNING · Yoga could be key to healthy routine ...
• Keith Lawson - Winston-Salem Journal April 3, 2018 Winston-Salem JournalKeith LawsonWinston-Salem JournalKeith Lawson participates in Rock Steady Boxing, a class specially designed for people with Parkinson's. J. SINCLAIR PHOTO. Facebook · Twitter · Email; Print; Save. Before he was diagnosed with Parkinson's Disease, Keith Lawson noticed his writing was ...
• Parkinson's Disease Treatment Archives - FigureAuto April 17, 2019 Parkinson's Disease Treatment Archives  FigureAutoGlobal Parkinson's Disease Treatment Market 2019, Trend, CAGR Status, Growth, Analysis and Forecast to 2024 · General News Parkinson's Disease ...
• Nitration and glycation diminish the α-synuclein role on the formation and scavenging of Cu2+-catalyzed reactive oxygen species. April 12, 2019 Nitration and glycation diminish the α-synuclein role on the formation and scavenging of Cu2+-catalyzed reactive oxygen species. ACS Chem Neurosci. 2019 Apr 11;: Authors: Martinez Orozco H, Mariño L, Uceda AB, Ortega-Castro J, Vilanova B, Frau J, Adrover M Abstract Human α-synuclein is a small monomeric protein (140 residues) essential to maintain the function of the dopaminergic neurons and the…
• The Bill and Melinda burden study October 4, 2018   Determining exactly how many individuals there are in the world that are affected by Parkinson’s is a difficult task. Previously, a lot of ‘gues-stimation’ has been used in these quantitative efforts. But a clearer idea of the geographical, national and regional spread of Parkinson’s burden, could provide us with very useful information to help better understand the condition. The…
• Parkinson's Disease Treatment Research and Markets Archives - FigureAuto April 17, 2019 Parkinson's Disease Treatment Research and Markets Archives  FigureAutoGlobal Parkinson's Disease Treatment Market 2019, Trend, CAGR Status, Growth, Analysis and Forecast to 2024 · General News Parkinson's Disease ...
• The Parkinson’s Home Safety Checklist June 5, 2018 Making your home safe and comfortable is an important part of living well with Parkinson’s. That’s why we’ve spent the past couple of months asking people with Parkinson’s, occupational therapists (OTs), physical therapists (PTs) and care partners some of the most instrumental changes people with Parkinson’s can make to ensure their home is as safe and as comfortable as possible.…
• CBS This Morning Co-Anchor Norah O'Donnell Undergoes Emergency Appendix Surgery - PEOPLE.com March 23, 2019 CBS This Morning Co-Anchor Norah O'Donnell Undergoes Emergency Appendix Surgery  PEOPLE.comNorah O'Donnell documented her experience on Instagram, writing, "not what we planned for spring break"
• Brain Trust: No Laughing Matter : Emergency Medicine News - LWW Journals April 1, 2019 Brain Trust: No Laughing Matter : Emergency Medicine News  LWW JournalsMarcolini, Evie, MD. Emergency Medicine News: April 2019 - Volume 41 - Issue 4 - p 8. doi: 10.1097/01.EEM.0000554843.16626.01. Brain Trust. Article Outline ...
• Matched Cohort Analysis of Total Hip Arthroplasty in Patients With and Without Parkinson's Disease: Complications, Mortality, Length of Stay, and Hospital Charges. April 16, 2019 Related ArticlesMatched Cohort Analysis of Total Hip Arthroplasty in Patients With and Without Parkinson's Disease: Complications, Mortality, Length of Stay, and Hospital Charges. J Arthroplasty. 2019 Mar 14;: Authors: Kleiner JE, Eltorai AEM, Rubin LE, Daniels AH Abstract BACKGROUND: Increased complication rate has been reported in Parkinson's disease (PD) patients following total hip arthroplasty (THA). However, this has not previously…
• Jesse Jackson appears to give Biden chilly response after civil rights speech | TheHill - The Hill June 28, 2019 Jesse Jackson appears to give Biden chilly response after civil rights speech | TheHill  The HillProminent civil rights leader the Rev. Jesse Jackson appeared to avoid embracing former Vice President Joe Biden · Joe BidenAtlanta mayor endorses Biden for ...